Metastatic Castration Sensitive Prostate Cancer (mCSPC) trials recruiting in Arkansas

Fewer than 3 recruiting trials found.

All Metastatic Castration Sensitive Prostate Cancer (mCSPC) trials nationally

1

Recruiting in Arkansas

3

Cities with sites

Cities in Arkansas

Fayetteville 1Rogers 1Springdale 1

Recruiting trials in Arkansas

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
NCT07028853 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · Arkansas: Fayetteville, Rogers, Springdale

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.